×

Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.

Award Committee

PCF Leadership

  • Charles (Chuck) J. Ryan, MD
  • Howard R. Soule, PhD, Chief Science Officer and Executive Vice President
  • Stuart Holden, MD, Medical Director
  • Andrea Miyahira, PhD, Director, Global Research and Scientific Communications
  • Development & Translation Committee, PCF Board of Directors

 

Surgical Urologic Oncology

  • William Aronson, MD, University of California, Los Angeles
  • Neil Bander, MD, Weill Cornell Medicine
  • Christopher Barbieri, MD, PhD, Weill Cornell Medicine
  • Wayne Brisbane, MD, University of Florida
  • Brett Carver, MD, Memorial Sloan Kettering Cancer Center
  • Adam Feldman, MD, Harvard: Massachusetts General Hospital
  • Stephen Freedland, MD, Cedars Sinai Medical Center
  • Isla Garraway, MD, PhD, University of California, Los Angeles
  • Jeffrey Jones, MD, Michael E. DeBakey VA Medical Center
  • Rakesh Heer, MBBS, PhD, Newcastle University
  • Hing Leung, MBBS, PhD, University of Glasgow – Cancer Research UK Beatson Institute
  • Stacy Loeb, MD, New York University
  • Danil Makarov, MD, New York University
  • Todd Morgan, MD, University of Michigan
  • Hao Nguyen, MD, PhD, University of California, San Francisco
  • Mark Preston, MD, MPH, University of California, San Diego
  • Ganesh Raj, MD, PhD, University of Texas Southwestern
  • Robert Reiter, MD, University of California, Los Angeles
  • Simpa Salami, MD, University of Michigan
  • Martin Sanda, MD, Emory University
  • Jeffrey Tosoian, MD, Vanderbilt University
  • Quoc-Dien Trinh, MD, Harvard: Brigham and Women’s Hospital

 

Medical Oncology and Treatment Sciences

  • Rahul Aggarwal, MD, University of California, San Francisco
  • Joshi Alumkal, MD, University of Michigan
  • Emmanuel Antonarakis, MD, University of Minnesota
  • Ana Aparicio, MD, The University of Texas MD Anderson Cancer Center
  • Andrew Armstrong, MD, Duke University
  • Gerhardt Attard, MD, PhD, University College London
  • Himisha Beltran, MD, Weill Cornell Medicine
  • William Berry, MD, Duke University
  • Hala Borno, MD, University of California San Francisco
  • Rohit Bose, MD, PhD, University of California San Francisco
  • Frank Cackowski, MD, PhD, Wayne State University
  • Megan Caram, MD, University of Michigan
  • Maria Carlo, MD, Memorial Sloan Kettering Cancer Center
  • Elena Castro, MD, PhD, Spanish National Cancer Research Centre
  • Heather Cheng, MD, PhD, University of Washington
  • Michael Cheng, MD, Harvard: Dana-Farber Cancer Institute
  • Atish Choudhury, MD, PhD, Harvard: Dana-Farber Cancer Institute
  • Suzanne Conzen, MD, University of Texas Southwestern
  • Johannes Czernin, MD, University of California, Los Angeles
  • William Dahut, MD, National Cancer Institute
  • Johann de Bono, MD, PhD, Institute of Cancer Research, Royal Marsden Hospital
  • Samuel Denmeade, MD, Johns Hopkins University
  • Terence Friedlander, MD, University of California, San Francisco
  • Daniel George, MD, Duke University
  • Anis Hamid, MBBS, University of Melbourne
  • Jessica Hawley, MD, University of Washington
  • Elisabeth Heath, MD, Wayne State University
  • Andrew Hsieh, MD, Fred Hutchinson Cancer Research Center
  • Maha Hussain, MD, Northwestern University
  • Anthony Michael Joshua, MD, PhD, Kinghorn Cancer Centre
  • Philip Kantoff, MD, Memorial Sloan Kettering Cancer Center
  • William K. Kelly, DO, Thomas Jefferson University
  • Vadim Koshkin, MD, University of California, San Francisco
  • Christos Kyriakopoulos, MD, University of Wisconsin
  • Joshua Lang, MD, University of Wisconsin
  • Richard Lee, MD, PhD, Harvard: Massachusetts General Hospital
  • Christopher Logothetis, MD, The University of Texas MD Anderson Cancer Center
  • Mark Markowski, MD, PhD, Johns Hopkins University
  • Joaquin Mateo, MD, PhD, Vall d’Hebron Institute of Oncology
  • Kara Maxwell, MD, PhD, University of Pennsylvania (Corporal Michael J. Crescenz VA Medical Center)
  • Nicholas Mitsiades, MD, PhD, Baylor College of Medicine
  • Alicia Morgans, MD, MPH, Harvard: Dana-Farber Cancer Institute
  • Michael Morris, MD, Memorial Sloan Kettering Cancer Center
  • Elahe Mostaghel, MD, PhD, Fred Hutchinson Cancer Research Center
  • Vivek Narayan, MD, University of Pennsylvania
  • Peter Nelson, MD, Fred Hutchinson Cancer Research Center
  • William Nelson, MD, PhD, Johns Hopkins University
  • David Oh, MD, PhD, University of California, San Francisco
  • William Oh, MD, Icahn School of Medicine at Mount Sinai Hospital
  • Ravi Parikh, MD, University of Pennsylvania (Corporal Michael J. Crescenz VA Medical Center)
  • Alec Paschalis, MBBS, Institute of Cancer Research
  • Kenneth Pienta, MD, Johns Hopkins University
  • Roberto Pili, MD, Roswell Park Cancer Institute
  • Mark Pomerantz, MD, Harvard: Dana-Farber Cancer Institute
  • Edwin Posadas, MD, Cedars-Sinai Medical Center
  • Dana Rathkopf, MD, Memorial Sloan Kettering Cancer Center
  • Pasquale Rescigno, MD, Candiolo Institute of Cancer Research
  • Matthew Rettig, MD, University of California, Los Angeles
  • Joshua Russo, MD, PhD, Harvard: Beth Israel Deaconess Medical Center
  • Oliver Sartor, MD, Tulane University
  • Philip Saylor, MD, Harvard: Massachusetts General Hospital
  • Howard Scher, MD, Memorial Sloan Kettering Cancer Center
  • Nima Sharifi, MD, Cleveland Clinic
  • Adam Sharp, MD, PhD, Institute of Cancer Research, Royal Marsden Hospital
  • Eric Small, MD, University of California, San Francisco
  • Matthew Smith, MD, PhD, Harvard: Massachusetts General Hospital
  • Walter Stadler, MD, University of Chicago
  • Christopher Sweeney, MBBS, Harvard: Dana-Farber Cancer Institute
  • Scott Tagawa, MD, Weill Cornell Medicine
  • David Takeda, MD, PhD, National Cancer Institute
  • Mary-Ellen Taplin, MD, Harvard: Dana-Farber Cancer Institute
  • Alok Tewari, MD, PhD, Harvard: Dana-Farber Cancer Institute
  • Eliezer Van Allen, MD, Harvard: Dana-Farber Cancer Institute
  • David VanderWeele, MD, PhD, Northwestern University
  • Srinivas Viswanathan, MD, PhD, Harvard: Dana-Farber Cancer Institute
  • Evan Yu, MD, University of Washington
  • David Wise, MD, PhD, New York University
  • Samir Zaidi, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Jimmy Zhao, MD, PhD, Memorial Sloan Kettering Cancer Center

 

Immunotherapy

  • Nathaniel Brennen, PhD, Johns Hopkins University
  • George Coukos, MD, PhD, University of Lausanne
  • Charles Drake, MD, PhD, Columbia University
  • Lawrence Fong, MD, University of California, San Francisco
  • Stephen Forman, MD, City of Hope
  • Julie Graff, MD, VA Portland Health Care System
  • James Gulley, MD, PhD, National Cancer Institute
  • Fatima Karzai, MD, National Cancer Institute
  • Haydn Kissick, PhD, Emory University
  • Marcin Kortylewski, PhD, City of Hope
  • Benjamin Larman, PhD, Johns Hopkins University
  • Ravi Madan, MD, National Cancer Institute
  • Douglas McNeel, MD, PhD, University of Wisconsin
  • Amy Moran, PhD, Oregon Health & Science University
  • Paul Nghiem, MD, PhD, University of Washington
  • Brian Olson, PhD, University of Chicago
  • Russell Pachynski, MD, Washington University
  • Eileen Parkes, MD, PhD, University of Oxford
  • Saul Priceman, PhD, City of Hope
  • William Redmond, PhD, Providence Portland Medical Center
  • Jinjun Shi, PhD, Harvard: Brigham and Women’s Hospital
  • Sumit Subudhi, MD, PhD, The University of Texas, MD Anderson Cancer Center
  • Jennifer Wu, PhD, Northwestern University
  • Jelani Zarif, PhD, Johns Hopkins University

 

Genomics / Bioinformatics

  • Saud AlDubayan, MD, Harvard: Dana-Farber Cancer Institute
  • Juan Arriaga, PhD, Icahn School of Medicine at Mount Sinai Hospital
  • Paul Boutros, PhD, MBA, University of California, Los Angeles
  • Marcin Cieslik, PhD, University of Michigan
  • Francesca Demichelis, PhD, Universita’ degli Studi di Trento
  • Michael Evans, PhD, University of California, San Francisco
  • Sachin Kumar Gupta, PhD, Baylor College of Medicine
  • William Hahn, MD, PhD, Harvard: Dana-Farber Cancer Institute
  • Hannelore Heemers, PhD, Cleveland Clinic
  • Christopher Haiman, ScD, University of Southern California
  • William Isaacs, PhD, Johns Hopkins University
  • Jun Luo, PhD, Johns Hopkins University
  • Christopher Maher, PhD, Washington University
  • Antonina Mitrofanova, PhD, Rutgers Cancer Institute of New Jersey
  • Yashar Niknafs, PhD, University of Michigan
  • Colin Pritchard, MD, PhD, University of Washington
  • David Quigley, PhD, University of California, San Francisco
  • Nikolaus Schultz, PhD, Memorial Sloan Kettering Cancer Center
  • Elizabeth Wasmuth, PhD, Memorial Sloan Kettering Cancer Center
  • Alexander Wyatt, PhD, Vancouver Prostate Centre

 

Basic Science

  • Cory Abate-Shen, PhD, Columbia University
  • Dario Altieri, MD, Wistar Institute
  • Sarah Amend, PhD, Johns Hopkins University
  • Irfan Asangani, PhD, University of Pennsylvania
  • Mohammad Asim, PhD, University of Surrey
  • Steven Balk, MD, PhD, Harvard: Beth Israel Deaconess Medical Center
  • Charles Bieberich, PhD, University of Maryland
  • Chad Brenner, PhD, University of Michigan
  • Qi Cao, PhD, The Methodist Hospital Research Institute
  • Yu Chen, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Lisa Chesner, PhD, University of California, San Francisco
  • Jonathan Chou, MD, PhD, University of California, San Francisco
  • Scott Dehm, PhD, University of Minnesota
  • Renée de Leeuw, PhD, University of Illinois at Chicago
  • Eleonora Dondossola, PhD, The University of Texas MD Anderson Cancer Center
  • Leigh Ellis, PhD, Cedars Sinai Medical Center
  • Claire Fletcher, PhD, Imperial College London
  • Andrew Goldstein, MD, University of California, Los Angeles
  • Rebecca Graff, ScD, University of California, San Francisco
  • Geraldine Gueron, PhD, Iquibicen-Conicet
  • Amanda Hargrove, PhD, Duke University
  • Christopher Heaphy, PhD, Boston University
  • Anastasia Hepburn, PhD, Newcastle University
  • Haojie Huang, PhD, Mayo Clinic
  • John Isaacs, PhD, Johns Hopkins University
  • Christina Jamieson, PhD, University of California, San Diego
  • Kalpana Kannan, PhD, Baylor College of Medicine
  • Salma Kaochar, PhD, Baylor College of Medicine
  • Wouter Karthous, PhD, Memorial Sloan Kettering Cancer Center
  • Steven Kregel, PhD, Loyola University Chicago
  • Sheng-Yu Ku, PhD, Harvard: Dana-Farber Cancer Institute
  • Rajan Kulkarni, MD, PhD, Oregon Health & Science University
  • Natasha Kyprianou, PhD, Icahn School of Medicine at Mount Sinai Hospital
  • David Labbé, PhD, Harvard: Dana-Farber Cancer Institute
  • Marikki Laiho, MD, PhD, Johns Hopkins University
  • Hung-Ming Lam, PhD, University of Washington
  • Lucia Languino, PhD, Thomas Jefferson University
  • Aaron LeBeau, PhD, University of Wisconsin
  • Hui Li, PhD, University of California, San Francisco
  • Shyh-Dar Li, PhD, The University of British Columbia
  • Shawn Lupold, PhD, Johns Hopkins University
  • Everardo Macias, PhD, Duke University
  • Nupam Mahajan, PhD, Washington University
  • Alan Meeker, MD, PhD, Johns Hopkins University
  • Ping Mu, PhD, University of Texas Southwestern
  • David Mulholland, PhD, Icahn School of Medicine at Mount Sinai Hospital
  • Lucia Nappi, MD, PhD, University of British Columbia
  • Nora Navone, MD, PhD, The University of Texas MD Anderson Cancer Center
  • Jung Wook Park, PhD, Duke University
  • Steven Patierno, PhD, Duke University
  • Ramon Parsons, MD, PhD, Icahn School of Medicine at Mount Sinai Hospital
  • Sethuramasundaram Pitchiaya, PhD, University of Michigan
  • Stephen Plymate, MD, University of Washington
  • Veronica Rodriguez-Bravo, PhD, Mayo Clinic
  • Anirban Sahu, MD, University of Michigan
  • Jack Schalken, PhD, University Hospital of Nijmegen
  • Matthew Schiewer, PhD, Thomas Jefferson University
  • Luke Selth, PhD, University of Adelaide
  • Karen Sfanos, PhD, Johns Hopkins University
  • Ayesha Shafi, PhD, HJF – Henry Jackson Foundation for the Advancement of Military Medicine / Uniformed Services University
  • Michael Shen, PhD, Columbia University
  • Yusuke Shiozawa, MD, PhD, Wake Forest School of Medicine
  • Adam Sowalsky, PhD, National Cancer Institute
  • Tanya Stoyanova, PhD, Stanford University
  • Timothy Thompson, PhD, The University of Texas MD Anderson Cancer Center
  • Jean Tien, PhD, University of Michigan
  • Hung-Ji Tsai, PhD, Johns Hopkins University
  • David Ulmert, MD, PhD, University of California, Los Angeles
  • Scott Wilkinson, PhD, National Cancer Institute
  • Shaomeng Wang, PhD, University of Michigan
  • Yuzhuo Wang, PhD, BC Cancer Agency
  • Li Xin, PhD, University of Washington
  • Kexin Xu, PhD, University of Texas Health Science Center at San Antonio
  • Srinivasan Yegnasubramanian, MD, PhD, Johns Hopkins University
  • Jindan Yu, MD, PhD, Northwestern University
  • Di Zhao, PhD, The University of Texas MD Anderson Cancer Center
  • Amina Zoubeidi, PhD, University of British Columbia

 

Radiation Oncology

  • Robert Bristow, MD, PhD, Manchester Cancer Research Centre
  • Adam Dicker, MD, PhD, Thomas Jefferson University
  • Jason Efstathiou, MD, PhD, Harvard: Massachusetts General Hospital
  • Felix Feng, MD, University of California, San Francisco
  • Ariel Marciscano, MD, Weill Cornell Medicine
  • David Miyamoto, MD, PhD, Harvard: Massachusetts General Hospital
  • Kent Mouw, MD, PhD, Harvard: Harvard: Dana-Farber Cancer Institute
  • Paul Nguyen, MD, Harvard: Harvard: Dana-Farber Cancer Institute
  • Nicholas Nickols, MD, PhD, University of California, Los Angeles
  • Zachery Reichert, MD, PhD, University of Michigan
  • Tyler Seibert, MD, PhD, University of California, San Diego
  • Daniel Spratt, MD, Case Western Reserve
  • Phuoc Tran, MD, PhD, Johns Hopkins University
  • Scott Williams, MD, Peter MacCallum Cancer Centre

 

Molecular Imaging (Radiology)

  • Steve Cho, MD, University of Wisconsin
  • Peter Choyke, MD, National Cancer Institute
  • Jeremy Durack, MD, Memorial Sloan Kettering Cancer Center
  • Robert Flavell, MD, PhD, University of California, San Francisco
  • Francesco Giganti, MD, University College London
  • Michael Hahn, MD, PhD, University of California, San Diego
  • Stefanie Hectors, PhD, Weill Cornell Medicine
  • Thomas Hope, MD, University of California, San Francisco
  • Joseph Ippolito, MD, PhD, Washington University
  • Robert Jeraj, PhD, University of Wisconsin
  • Stephanie Harmon, PhD, National Cancer Institute
  • John Kurhanewicz, PhD, University of California, San Francisco
  • Steven Larson, MD, Memorial Sloan Kettering Cancer Center
  • Jason Lewis, PhD, Memorial Sloan Kettering Cancer Center
  • Raquel Perez-Lopez, PhD, Vall d’Hebron Institute of Oncology
  • Martin Pomper, MD, PhD, Johns Hopkins University
  • Steven Rowe, MD, PhD, Johns Hopkins University
  • Daniel Thorek, PhD, Johns Hopkins University
  • Lily Wu, MD, PhD, University of California, Los Angeles
  • Huihui Ye, MD, University of California, Los Angeles

 

Molecular Pathology

  • Gustavo Ayala, MD, University of Texas Health Science Center
  • Tarek Bismar, MD, University of Calgary
  • Angelo DeMarzo, MD, PhD, Johns Hopkins University
  • Stephen Finn, MBBS, PhD, University of Dublin, Trinity College
  • Michael Haffner, MD, Fred Hutchinson Cancer Research Center
  • Jiaoti Huang, MD, PhD, Duke University
  • Michael Ittmann, MD, PhD, Baylor College of Medicine
  • Beatrice Knudsen, MD, PhD, University of Utah
  • Massimo Loda, MD, Weill Cornell Medicine
  • Tamara Lotan, MD, Johns Hopkins University
  • Rohit Mehra, MD, University of Michigan
  • David Rickman, PhD, Weill Cornell Medicine
  • Antonio Rodriguez-Calero, MD, University of Bern
  • Mark Rubin, MD, University of Bern
  • Jeffrey Simko, MD, PhD, University of California, San Francisco

 

Epidemiology / Observational Research

  • Peter Gann, MD, ScD, University of Illinois
  • Susan Halabi, PhD, Duke University
  • Sarah Holt, PhD, Fred Hutchinson Cancer Research Center
  • Corinne Joshu, PhD, Johns Hopkins University
  • Stacey Kenfield, ScD, University of California, San Francisco
  • Heather Montie, PhD, Philadelphia College of Osteopathic Medicine
  • Lorelei Mucci, ScD, MPH, Harvard School of Public Health
  • Kathryn Penney, ScD, Harvard: Dana-Farber Cancer Institute
  • Timothy Rebbeck, PhD, Harvard: Dana-Farber Cancer Institute
  • Meir Stampfer, MD, Harvard School of Public Health
  • Konrad Stopsack, MD, MPH, Memorial Sloan Kettering Cancer Center
  • Bruce Trock, PhD, Johns Hopkins University
  • Leanne Woods-Burnham, PhD, City of Hope

 

Nuclear Medicine

  • Jeremie Calais, MD, University of California, Los Angeles
  • Johannes Czernin, MD, University of California, Los Angeles
  • Andrei Gafita, MD, University of California, Los Angeles
  • Michael Hofman, MBBS, Peter MacCallum Cancer Centre